000 | 01040 a2200301 4500 | ||
---|---|---|---|
005 | 20250518075333.0 | ||
264 | 0 | _c20201215 | |
008 | 202012s 0 0 eng d | ||
022 | _a2374-2445 | ||
024 | 7 |
_a10.1001/jamaoncol.2019.4601 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKonstantinopoulos, Panagiotis A | |
245 | 0 | 0 |
_aBRCA Mutations and Homologous Recombination Repair Deficiency in Treatment With Niraparib Combined With Pembrolizumab-Reply. _h[electronic resource] |
260 |
_bJAMA oncology _c03 2020 |
||
300 |
_a441 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndazoles |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aOvarian Neoplasms |
650 | 0 | 4 | _aPiperidines |
650 | 0 | 4 | _aRecombinational DNA Repair |
700 | 1 | _aVinayak, Shaveta | |
773 | 0 |
_tJAMA oncology _gvol. 6 _gno. 3 _gp. 441 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoncol.2019.4601 _zAvailable from publisher's website |
999 |
_c30459395 _d30459395 |